Cargando…
Apelin and apelin receptor expression in renal cell carcinoma
BACKGROUND: The APLNR (apelin receptor) has been shown to be an essential gene for cancer immunotherapy, with deficiency in APLNR leading to immunotherapy failure. The aim of this study is to investigate the expression of APLN (apelin) and APLNR in patients with renal cell carcinoma (RCC), and its a...
Autores principales: | Tolkach, Yuri, Ellinger, Jörg, Kremer, Anika, Esser, Laura, Müller, Stefan C., Stephan, Carsten, Jung, Klaus, Toma, Marieta, Kristiansen, Glen, Hauser, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461937/ https://www.ncbi.nlm.nih.gov/pubmed/30783205 http://dx.doi.org/10.1038/s41416-019-0396-7 |
Ejemplares similares
-
On Methods for the Measurement of the Apelin Receptor Ligand Apelin
por: Janssens, Peter, et al.
Publicado: (2022) -
Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior
por: Simon, Adrian Georg, et al.
Publicado: (2020) -
The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles
por: Jiang, Yunlu, et al.
Publicado: (2021) -
Systematic expression analysis of m(6)A RNA methyltransferases in clear cell renal cell carcinoma
por: Gundert, Larissa, et al.
Publicado: (2021) -
Temporal Expression of Apelin/Apelin Receptor in Ischemic Stroke and its Therapeutic Potential
por: Wu, Yili, et al.
Publicado: (2017)